Does receptor specificity define algogenic properties of propofol and fospropofol?
The lack of algogenic activity in fospropofol is most likely the result of its inability to activate TRPA1 on nociceptors.
This study supports evidence of TNF as a predictive biomarker in regimen-related gastrointestinal toxicity. Confirming these findings in a larger cohort is warranted.